Nova Eye Medical Limited
ELXMF
$0.10
-$0.086-46.24%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 23.51% | 30.11% | 38.23% | 36.94% | 33.51% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.51% | 30.11% | 38.23% | 36.94% | 33.51% |
| Cost of Revenue | 57.21% | 73.09% | 101.00% | 119.41% | 140.98% |
| Gross Profit | 10.51% | 16.20% | 22.35% | 18.97% | 13.91% |
| SG&A Expenses | 15.45% | 4.47% | -5.30% | -15.26% | -25.19% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -1.81% | 18.76% | 48.82% | 85.60% | 144.51% |
| Total Operating Expenses | 16.81% | 18.07% | 19.41% | 15.23% | 9.26% |
| Operating Income | 0.64% | 8.35% | 15.24% | 20.20% | 25.81% |
| Income Before Tax | -2.26% | 29.69% | 47.22% | 48.15% | 49.74% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.26% | 24.42% | 40.83% | 42.10% | 44.10% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.26% | 24.42% | 40.83% | 42.10% | 44.10% |
| EBIT | 0.64% | 8.35% | 15.24% | 20.20% | 25.81% |
| EBITDA | -12.51% | 15.77% | 34.98% | 36.21% | 38.66% |
| EPS Basic | 15.92% | 40.63% | 53.93% | 54.83% | 56.08% |
| Normalized Basic EPS | 15.56% | 24.88% | 32.03% | 35.98% | 40.20% |
| EPS Diluted | 15.92% | 40.63% | 53.93% | 54.83% | 56.08% |
| Normalized Diluted EPS | 15.56% | 24.88% | 32.03% | 35.98% | 40.20% |
| Average Basic Shares Outstanding | 21.16% | 23.10% | 25.32% | 27.92% | 30.89% |
| Average Diluted Shares Outstanding | 21.16% | 23.10% | 25.32% | 27.92% | 30.89% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |